• LAST PRICE
    0.1000
  • TODAY'S CHANGE (%)
    Trending Down-0.0081 (-7.4931%)
  • Bid / Lots
    0.0870/ 100
  • Ask / Lots
    0.1399/ 50
  • Open / Previous Close
    0.1075 / 0.1081
  • Day Range
    Low 0.1000
    High 0.1100
  • 52 Week Range
    Low 0.0590
    High 0.1670
  • Volume
    17,000
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.1081
TimeVolumePURE
03:12 ET50000.1075
03:17 ET120000.1
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPURE
PURE Biosciences Inc
12.1M
-3.3x
---
United StatesZONE
CleanCore Solutions Inc
13.2M
-4.6x
---
United StatesMGON
Megola Inc
3.8M
---
---
United StatesWDFC
WD-40 Co
3.8B
56.1x
+1.93%
United StatesREYN
Reynolds Consumer Products Inc
5.8B
15.9x
+10.32%
United StatesCLX
Clorox Co
21.0B
58.2x
-18.70%
As of 2024-11-26

Company Information

PURE Bioscience, Inc. is a creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial. The Company is focused on developing and commercializing its proprietary antimicrobial products, primarily in the food and beverage industry. It provides solutions to combat the health and environmental challenges of pathogens and hygienic control. Its technology platform is based on patented, stabilized ionic silver, and its initial products contain SDC. Its registered offerings include PURE Hard Surface, a food contact surface sanitizer and disinfectant designed for restaurant chains, food processors, and transportation companies, as well as PURE Control, a direct food contact processing aid. It also supplies SDC-based formulations as raw material ingredients for personal care products. Its SDC-based disinfecting and sanitizing products are registered with the United States Environmental Protection Agency, the United States Food and Drug Administration, and Health Canada.

Contact Information

Headquarters
771 Jamacha Road #512EL CAJON, CA, United States 92019
Phone
619-596-8600
Fax
619-596-8690

Executives

Independent Chairman of the Board
Ivan Chen
President, Chief Executive Officer, Director
Robert Bartlett
Principal Financial Officer, Principal Accounting Officer, Vice President - Finance
Mark Elliott
Executive Vice President - Technology and Development, Director
Tom Myers
Director
Tom Lee

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$12.1M
Revenue (TTM)
$2.0M
Shares Outstanding
111.9M
PURE Biosciences Inc does not pay a dividend.
Beta
0.03
EPS
$-0.03
Book Value
$-0.03
P/E Ratio
-3.3x
Price/Sales (TTM)
6.2
Price/Cash Flow (TTM)
---
Operating Margin
-162.56%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.